Info

Invirion Diagnostics, LLC is the first theranostics company dedicated to the detection, monitoring and treatment of life-threatening viral diseases such as HIV/AIDS, cervical cancer, and organ transplant rejection. Invirion was founded in 1999 with the goal of commercializing state-of-the-art molecular virology technology to make a difference in people's lives. Invirion's research, development, and commercialization efforts are focused on monitoring viruses that cause human disease and using the information gleaned from these novel assays to develop therapeutic products that rationally target the viral lifecycle. Invirion currently sells viral load monitoring assays for HIV, the virus that causes AIDS; SIV, the HIV animal model used in vaccine design; and HPV, the virus associated with cervical cancer, and HCV, the virus implicated in cirrhosis and liver cancer. In addition, Invirion is set to launch an HIV phenotyping assay that cuts the current assay time and cost by 75% and a pap smear specimen adequacy test that will reduce the number of repeat visits to the physician by women with inadequate pap specimens.